This is consistent with the observation of high LLT1 expression within DZ B cells (Fig. 1G, 1H), plasmablasts (Fig. 2), and B cell lymphomas (see Fig. 6). This evidence concerns the gene CLEC2D and B-cell non-Hodgkin lymphoma.